Welcome to our dedicated page for Transdigm Group SEC filings (Ticker: TDG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
TransDigm Group Incorporated filings document operating results, material events and capital-structure activity for an aerospace components company listed on the New York Stock Exchange under TDG. Form 8-K reports include quarterly financial results, conference-call materials, acquisition-related events and exhibits furnished with company press releases.
The filing record also covers financing arrangements at subsidiary TransDigm Inc., including senior subordinated notes, term loans, indenture and guarantee disclosures. Governance filings report annual meeting voting outcomes, director elections, auditor ratification and advisory executive-compensation votes, alongside common-stock registration details and other material agreements.
TransDigm Group (TDG) reported an insider equity award. Director Kevin Stein acquired 518 stock options on 11/04/2025 with an exercise price of $1,291.97.
The options vest 20% per year over five years beginning September 30, 2026, subject to annual operating performance targets, and expire on 11/04/2035. Following the grant, 518 derivative securities were beneficially owned on a direct basis.
TransDigm Group (TDG) reported a Form 4 showing a grant of 26,450 stock options to a Co‑Chief Operating Officer at an exercise price of $1,291.97 on November 4, 2025.
The options vest 20% per year over five years beginning September 30, 2026, subject to annual operating performance targets, and expire on November 4, 2035. Following the transaction, 26,450 derivative securities were beneficially owned, held directly. Transaction code: A (award).
TransDigm Group (TDG) reported an insider equity award. Officer Armani Vadiee (GC, CCO, Secretary) received a grant of 17,100 stock options on 11/04/2025 at an exercise price of $1,291.97 per share. The options expire on 11/04/2035.
Per the grant terms, the options vest at 20% per year over five years beginning September 30, 2026, subject to the achievement of annual operating performance targets each year. Following the reported transaction, 17,100 derivative securities were beneficially owned, held direct.
TransDigm Group (TDG) reported a Form 4 for CFO Sarah Wynne showing a grant of 8,700 stock options on 11/04/2025 with an exercise price of $1,291.97 per share.
The options vest 50% in 2029 and 50% in 2030, subject to the achievement of annual operating performance targets, and expire on 11/04/2035. The filing lists direct ownership.
TransDigm Group (TDG) reported a Form 4 for Co‑Chief Operating Officer Joel Reiss, reflecting a grant of stock options for 9,700 shares at an exercise price of $1,291.97 on 11/04/2025.
The options expire on 11/04/2035 and are scheduled to vest 50% in 2029 and 50% in 2030, subject to achieving annual operating performance targets in each year. Following the grant, 9,700 derivative securities are beneficially owned on a direct basis.
TransDigm Group (TDG) disclosed a Form 4 showing its President & CEO, Michael Lisman, received stock option grants on 11/04/2025. Two awards were reported with an exercise price of $1,291.97 and an expiration of 11/04/2035 (Transaction Code: A). The first grant covers 75,696 options; the second covers 3,907 options. Both were acquired at $0 for the derivative security and are listed as Direct (D) ownership.
Vesting is performance-based: the 75,696 options vest 20% per year over five years beginning September 30, 2026, subject to annual operating performance targets. The 3,907 options vest 80% in 2026 and 20% in 2027, subject to similar targets.
TransDigm Group (TDG) director filed an initial ownership report (Form 3) for an event on 10/23/2025.
The filing lists 4,000 shares of common stock (direct) and multiple stock options. Notable grants include 22,100 options at $559.78 (exercisable 09/30/2023, expiring 11/15/2029) and 17,160 options at $643 (exercisable 09/30/2025, expiring 11/12/2031). Additional options include 2,600 at $582.8 and 4,730 at $869.73.
Some options are held indirectly by a Family Trust (3,000 and 2,375 options at $476.81, expiring 04/25/2029). The report notes it was filed late by 2 days due to administrative delays.
TransDigm Group (TDG) reported an insider transaction by its Co‑Chief Operating Officer. On 11/03/2025, the officer exercised 290 stock options at $269.42 and on the same day sold 290 common shares at a weighted average price of $1,310 (within a range of $1,310.0000–$1,310.9999).
Following these transactions, the officer directly owns 1,055 common shares and holds 2,030 stock options outstanding.
TDG filed a Form 144 indicating a proposed sale of 290 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $379,467.90. The approximate sale date is 11/03/2025 on the NYSE.
The securities to be sold were acquired on 11/03/2025 via the exercise of stock options, paid in cash. Over the past three months, the filing lists a Rule 10b5-1 transaction for Patrick J. Murphy on 10/27/2025 totaling 580 shares for gross proceeds of $785,760.80. Shares outstanding are stated as 56,350,285.
TransDigm Group (TDG): insider transaction reported. On 10/27/2025, the Fortuna Trust dated June 1, 2018, affiliated with a company director, exercised 700 stock options at $105.88 and sold 700 common shares at an average $1,360. Following these transactions, the trust held 8,158 common shares indirectly. The option exercise related to a grant exercisable since 09/30/2018 and expiring 04/25/2028, with 72,800 derivative securities remaining indirectly held.